[
  {
    "row_id": "3070MO",
    "regimen": "LY3866288",
    "drugs": [
      "LY3866288"
    ],
    "biomarkers": [
      "FGFR3"
    ],
    "modality": [
      "TKI"
    ],
    "population": "Other",
    "line": "Not specified",
    "phase": "Phase 1",
    "trial_id": "FORAGER-1"
  },
  {
    "row_id": "LBA110",
    "regimen": "nivolumab + visugromab",
    "drugs": [
      "nivolumab",
      "visugromab"
    ],
    "modality": [
      "IO"
    ],
    "population": "MIBC",
    "line": "Neoadjuvant",
    "phase": "Phase 2",
    "trial_id": "Not specified",
    "biomarkers": []
  },
  {
    "row_id": "LBA112",
    "regimen": "gemcitabine intravesical system (TAR-200) + cetrelimab",
    "drugs": [
      "gemcitabine",
      "cetrelimab"
    ],
    "modality": [
      "Intravesical"
    ],
    "population": "MIBC",
    "line": "Neoadjuvant",
    "phase": "Not specified",
    "trial_id": "SunRISe-4",
    "biomarkers": []
  },
  {
    "row_id": "ROW_70",
    "regimen": "platinum-based chemotherapy â†’ avelumab maintenance",
    "drugs": [
      "platinum-based chemotherapy",
      "avelumab"
    ],
    "modality": [
      "Chemotherapy",
      "Maintenance"
    ],
    "population": "Other",
    "line": "Maintenance",
    "phase": "Phase 2",
    "trial_id": "Not specified",
    "biomarkers": []
  },
  {
    "row_id": "3071MO",
    "regimen": "Disitamab Vedotin + Tislelizumab",
    "drugs": [
      "Disitamab Vedotin",
      "Tislelizumab",
      "disitamab vedotin",
      "tislelizumab"
    ],
    "modality": [
      "ADC",
      "IO"
    ],
    "population": "UTUC",
    "line": "Not specified",
    "phase": "Phase 2",
    "trial_id": "DISTINCT-I",
    "biomarkers": []
  },
  {
    "row_id": "LBA108",
    "regimen": "durvalumab + BCG",
    "drugs": [
      "durvalumab",
      "BCG"
    ],
    "modality": [
      "IO",
      "Intravesical"
    ],
    "population": "NMIBC",
    "line": "Not specified",
    "phase": "Phase 3",
    "trial_id": "Not specified",
    "biomarkers": []
  },
  {
    "row_id": "3068O",
    "regimen": "nivolumab vs placebo",
    "drugs": [
      "nivolumab"
    ],
    "modality": [
      "IO"
    ],
    "population": "MIBC",
    "line": "Adjuvant",
    "phase": "Approved",
    "trial_id": "CheckMate 274",
    "biomarkers": []
  },
  {
    "row_id": "3069MO",
    "regimen": "durvalumab + neoadjuvant chemotherapy",
    "drugs": [
      "durvalumab"
    ],
    "modality": [
      "IO",
      "Chemotherapy"
    ],
    "population": "MIBC",
    "line": "Perioperative",
    "phase": "Not specified",
    "trial_id": "NIAGARA",
    "biomarkers": []
  },
  {
    "row_id": "LBA107",
    "regimen": "atezolizumab + BCG",
    "drugs": [
      "atezolizumab",
      "BCG"
    ],
    "modality": [
      "IO",
      "Intravesical"
    ],
    "population": "NMIBC",
    "line": "Not specified",
    "phase": "Phase 3",
    "trial_id": "Not specified",
    "biomarkers": []
  },
  {
    "row_id": "3072MO",
    "regimen": "Datopotamab deruxtecan + rilvegostomig",
    "drugs": [
      "Datopotamab deruxtecan",
      "rilvegostomig"
    ],
    "modality": [
      "ADC",
      "IO"
    ],
    "population": "mUC",
    "line": "Not specified",
    "phase": "Phase 2",
    "trial_id": "TROPION-PanTumor",
    "biomarkers": []
  },
  {
    "row_id": "3091P",
    "regimen": "Artificial Intelligence Predicts",
    "drugs": [],
    "modality": [],
    "population": "MIBC",
    "line": "Not specified",
    "phase": "Not specified",
    "trial_id": "Not specified",
    "biomarkers": []
  },
  {
    "row_id": "3111eP",
    "regimen": "enfortumab vedotin",
    "drugs": [
      "enfortumab vedotin"
    ],
    "population": "mUC",
    "phase": "Not specified",
    "trial_id": "3111eP",
    "biomarkers": []
  },
  {
    "row_id": "3083P",
    "regimen": "avelumab + sacituzumab govitecan",
    "drugs": [
      "avelumab",
      "sacituzumab govitecan"
    ],
    "population": "mUC",
    "line": "1L",
    "phase": "Phase 2",
    "trial_id": "3083P",
    "biomarkers": []
  },
  {
    "row_id": "3085P",
    "regimen": "tislelizumab combined with disitamab vedotin",
    "drugs": [
      "tislelizumab",
      "disitamab vedotin"
    ],
    "population": "Other",
    "phase": "Phase 2",
    "trial_id": "3085P",
    "biomarkers": []
  },
  {
    "row_id": "LBA2",
    "regimen": "enfortumab vedotin + pembrolizumab",
    "drugs": [
      "enfortumab vedotin",
      "pembrolizumab",
      "cisplatin"
    ],
    "population": "MIBC",
    "line": "Perioperative",
    "phase": "Not specified",
    "trial_id": "LBA2",
    "biomarkers": []
  },
  {
    "row_id": "3084P",
    "regimen": "Durvalumab +/- tremelimumab + ddMVAC",
    "drugs": [
      "Durvalumab",
      "tremelimumab",
      "ddMVAC",
      "durvalumab"
    ],
    "population": "MIBC",
    "line": "Neoadjuvant",
    "phase": "Phase 2",
    "trial_id": "3084P",
    "biomarkers": []
  },
  {
    "row_id": "3121eP",
    "regimen": "Durvalumab plus Platin-based Chemotherapy",
    "drugs": [
      "Durvalumab",
      "durvalumab"
    ],
    "population": "MIBC",
    "line": "Perioperative",
    "phase": "Not specified",
    "trial_id": "3121eP",
    "biomarkers": []
  },
  {
    "row_id": "3089P",
    "regimen": "enfortumab vedotin and pembrolizumab",
    "drugs": [
      "enfortumab vedotin",
      "pembrolizumab"
    ],
    "population": "mUC",
    "phase": "Not specified",
    "trial_id": "3089P",
    "biomarkers": []
  },
  {
    "row_id": "3102P",
    "regimen": "enfortumab vedotin and pembrolizumab",
    "drugs": [
      "enfortumab vedotin",
      "pembrolizumab"
    ],
    "biomarkers": [
      "FGFR3",
      "ERBB2",
      "HER2"
    ],
    "population": "mUC",
    "phase": "Not specified",
    "trial_id": "3102P"
  },
  {
    "row_id": "3098P",
    "regimen": "Fexagratinib",
    "drugs": [
      "Fexagratinib"
    ],
    "biomarkers": [
      "FGFR3"
    ],
    "population": "mUC",
    "phase": "Not specified",
    "trial_id": "3098P"
  },
  {
    "row_id": "3095P",
    "regimen": "enfortumab vedotin",
    "drugs": [
      "enfortumab vedotin"
    ],
    "biomarkers": [
      "ERBB2",
      "Nectin-4",
      "HER2"
    ],
    "population": "Other",
    "phase": "Not specified",
    "trial_id": "3095P"
  },
  {
    "row_id": "3088P",
    "regimen": "TAR-200",
    "drugs": [
      "TAR-200",
      "cisplatin"
    ],
    "population": "NMIBC",
    "phase": "Phase 2b",
    "trial_id": "3088P",
    "biomarkers": []
  },
  {
    "row_id": "3076P",
    "regimen": "RC48-ADC combined with tislelizumab",
    "drugs": [
      "RC48-ADC",
      "tislelizumab",
      "disitamab vedotin"
    ],
    "biomarkers": [
      "HER2"
    ],
    "population": "MIBC",
    "line": "Neoadjuvant",
    "phase": "Phase Ib/II",
    "trial_id": "3076P"
  },
  {
    "row_id": "3119eP",
    "regimen": "Bacillus Calmette-Guerin",
    "drugs": [
      "BCG"
    ],
    "population": "NMIBC",
    "phase": "Not specified",
    "trial_id": "3119eP",
    "biomarkers": []
  },
  {
    "row_id": "3093P",
    "regimen": "Sacituzumab Govitecan alone and with pembrolizumab",
    "drugs": [
      "Sacituzumab Govitecan",
      "pembrolizumab",
      "sacituzumab govitecan"
    ],
    "population": "MIBC",
    "phase": "Not specified",
    "trial_id": "3093P",
    "biomarkers": []
  },
  {
    "row_id": "3134eTiP",
    "regimen": "neoadjuvant Systemic Therapies",
    "drugs": [],
    "population": "Other",
    "phase": "Not specified",
    "trial_id": "3134eTiP",
    "biomarkers": []
  },
  {
    "row_id": "3096P",
    "regimen": "Immunotherapy",
    "drugs": [],
    "population": "mUC",
    "phase": "Not specified",
    "trial_id": "3096P",
    "biomarkers": []
  },
  {
    "row_id": "3108P",
    "regimen": "Enfortumab Vedotin",
    "drugs": [
      "enfortumab vedotin"
    ],
    "population": "Other",
    "phase": "Not specified",
    "trial_id": "3108P",
    "biomarkers": []
  },
  {
    "row_id": "3112eP",
    "regimen": "enfortumab vedotin",
    "drugs": [
      "enfortumab vedotin"
    ],
    "population": "mUC",
    "phase": "Not specified",
    "trial_id": "EVOLUTE",
    "biomarkers": []
  },
  {
    "row_id": "3078P",
    "regimen": "sasanlimab + Bacillus Calmette-Guerin",
    "drugs": [
      "sasanlimab",
      "Bacillus Calmette-Guerin"
    ],
    "population": "MIBC",
    "line": "1L",
    "phase": "Phase 3",
    "trial_id": "CREST",
    "biomarkers": []
  },
  {
    "row_id": "3128eP",
    "regimen": "Neoadjuvant Chemo-Immunotherapy",
    "biomarkers": [
      "PD-L1"
    ],
    "population": "MIBC",
    "line": "Neoadjuvant",
    "phase": "Not specified",
    "trial_id": "AURA",
    "drugs": []
  },
  {
    "row_id": "3075P",
    "regimen": "Adjuvant Therapy",
    "population": "UTUC",
    "line": "Adjuvant",
    "phase": "Not specified",
    "trial_id": "CURATE-UTUC",
    "drugs": [],
    "biomarkers": []
  },
  {
    "row_id": "3099P",
    "regimen": "BCG",
    "population": "NMIBC",
    "phase": "Not specified",
    "trial_id": "Not specified",
    "drugs": [],
    "biomarkers": []
  },
  {
    "row_id": "3116eP",
    "regimen": "advanced urothelial carcinoma",
    "population": "MIBC",
    "phase": "Not specified",
    "trial_id": "JAV",
    "drugs": [
      "avelumab"
    ],
    "biomarkers": []
  },
  {
    "row_id": "3073P",
    "regimen": "enfortumab vedotin + pembrolizumab",
    "drugs": [
      "enfortumab vedotin",
      "pembrolizumab"
    ],
    "population": "mUC",
    "line": "1L",
    "phase": "Not specified",
    "trial_id": "Not specified",
    "biomarkers": []
  },
  {
    "row_id": "3087P",
    "regimen": "enfortumab vedotin + pembrolizumab",
    "drugs": [
      "enfortumab vedotin",
      "pembrolizumab"
    ],
    "biomarkers": [
      "NECTIN4",
      "Nectin-4"
    ],
    "population": "mUC",
    "line": "1L",
    "phase": "Not specified",
    "trial_id": "Not specified"
  },
  {
    "row_id": "3090P",
    "regimen": "enfortumab vedotin",
    "drugs": [
      "enfortumab vedotin"
    ],
    "biomarkers": [
      "NECTIN4",
      "Nectin-4"
    ],
    "population": "mUC",
    "phase": "Not specified",
    "trial_id": "Not specified"
  },
  {
    "row_id": "3082P",
    "regimen": "Spatial Transcriptomics",
    "population": "Other",
    "phase": "Not specified",
    "trial_id": "SOGUG-AUREA",
    "drugs": [],
    "biomarkers": []
  },
  {
    "row_id": "3126eP",
    "regimen": "PET-CT",
    "population": "MIBC",
    "phase": "Not specified",
    "trial_id": "Not specified",
    "drugs": [],
    "biomarkers": []
  },
  {
    "row_id": "3092P",
    "regimen": "erdafitinib",
    "drugs": [
      "erdafitinib"
    ],
    "population": "mUC",
    "line": "1L",
    "phase": "Phase 3",
    "trial_id": "THOR",
    "biomarkers": []
  },
  {
    "row_id": "3135eTiP",
    "regimen": "intismeran autogene + Bacillus Calmette-Guerin",
    "drugs": [
      "intismeran autogene",
      "Bacillus Calmette-Guerin"
    ],
    "population": "NMIBC",
    "line": "1L",
    "phase": "Phase 2",
    "trial_id": "INTerpath-011",
    "biomarkers": []
  },
  {
    "row_id": "3120eP",
    "regimen": "Antibody-Drug Conjugates",
    "population": "Other",
    "phase": "Not specified",
    "trial_id": "Not specified",
    "drugs": [],
    "biomarkers": []
  },
  {
    "row_id": "ROW_907",
    "regimen": "adjuvant therapy",
    "population": "Other",
    "phase": "Not specified",
    "trial_id": "Not specified",
    "drugs": [],
    "biomarkers": []
  },
  {
    "row_id": "ROW_990",
    "regimen": "Not specified",
    "population": "Other",
    "phase": "Not specified",
    "trial_id": "Not specified",
    "drugs": [],
    "biomarkers": []
  },
  {
    "row_id": "ROW_1120",
    "regimen": "frontline therapy",
    "population": "Other",
    "phase": "Not specified",
    "trial_id": "Not specified",
    "drugs": [],
    "biomarkers": []
  },
  {
    "row_id": "ROW_1224",
    "regimen": "trimodality therapy",
    "population": "Other",
    "phase": "Not specified",
    "trial_id": "Not specified",
    "drugs": [],
    "biomarkers": []
  },
  {
    "row_id": "ROW_1240",
    "regimen": "neoadjuvant therapy",
    "population": "MIBC",
    "phase": "Not specified",
    "drugs": [],
    "biomarkers": []
  },
  {
    "row_id": "3109eP",
    "regimen": "avelumab first-line maintenance",
    "drugs": [
      "avelumab"
    ],
    "population": "mUC",
    "line": "1L",
    "phase": "Not specified",
    "trial_id": "Not specified",
    "biomarkers": []
  },
  {
    "row_id": "3122eP",
    "regimen": "platinum-based treatment",
    "population": "mUC",
    "line": "1L",
    "phase": "Not specified",
    "trial_id": "Not specified",
    "drugs": [],
    "biomarkers": []
  },
  {
    "row_id": "3106P",
    "regimen": "perioperative chemo-immunotherapy with Durvalumab",
    "drugs": [
      "Durvalumab",
      "durvalumab"
    ],
    "population": "MIBC",
    "line": "Perioperative",
    "phase": "Phase 2",
    "trial_id": "SAKK 06/17",
    "biomarkers": []
  },
  {
    "row_id": "3107P",
    "regimen": "intravesical recombinant BCG followed by perioperative chemo-immunotherapy",
    "population": "MIBC",
    "line": "Perioperative",
    "phase": "Not specified",
    "trial_id": "SAKK 06/19",
    "drugs": [],
    "biomarkers": []
  },
  {
    "row_id": "3100P",
    "regimen": "Enfortumab Vedotin Plus Pembrolizumab Therapy",
    "drugs": [
      "enfortumab vedotin",
      "pembrolizumab"
    ],
    "biomarkers": [
      "NECTIN-4",
      "Nectin-4"
    ],
    "population": "mUC",
    "phase": "Not specified",
    "trial_id": "Not specified"
  },
  {
    "row_id": "3129eP",
    "regimen": "neoadjuvant chemotherapy",
    "population": "MIBC",
    "phase": "Not specified",
    "trial_id": "Not specified",
    "drugs": [],
    "biomarkers": []
  },
  {
    "row_id": "3097P",
    "regimen": "AI Prediction Model",
    "population": "Other",
    "phase": "Not specified",
    "trial_id": "Not specified",
    "drugs": [],
    "biomarkers": []
  },
  {
    "row_id": "3127eP",
    "regimen": "Bulumtatug Fuvedotin combined with Toripalimab",
    "drugs": [
      "Bulumtatug Fuvedotin",
      "Toripalimab",
      "toripalimab"
    ],
    "population": "mUC",
    "phase": "Not specified",
    "trial_id": "Not specified",
    "biomarkers": [
      "Nectin-4"
    ]
  },
  {
    "row_id": "3077P",
    "regimen": "Enfortumab vedotin with pembrolizumab",
    "drugs": [
      "enfortumab vedotin",
      "pembrolizumab"
    ],
    "population": "mUC",
    "phase": "Not specified",
    "trial_id": "UNITE",
    "biomarkers": []
  },
  {
    "row_id": "3105P",
    "regimen": "Sex-Associated Outcomes in Enfortumab Vedotin-Treated",
    "drugs": [
      "enfortumab vedotin"
    ],
    "population": "mUC",
    "phase": "Not specified",
    "trial_id": "Not specified",
    "biomarkers": [
      "Nectin-4"
    ]
  },
  {
    "row_id": "3074P",
    "regimen": "enfortumab vedotin with or without pembrolizumab",
    "drugs": [
      "enfortumab vedotin",
      "pembrolizumab",
      "cisplatin"
    ],
    "population": "MIBC",
    "line": "1L",
    "phase": "Phase 2",
    "trial_id": "EV-103 Cohort K",
    "biomarkers": []
  },
  {
    "row_id": "3115eP",
    "regimen": "avelumab, pembrolizumab or enfortumab vedotin",
    "drugs": [
      "avelumab",
      "pembrolizumab",
      "enfortumab vedotin"
    ],
    "population": "mUC",
    "phase": "Not specified",
    "trial_id": "Not specified",
    "biomarkers": []
  },
  {
    "row_id": "3079P",
    "regimen": "Disitamab Vedotin plus BCG",
    "drugs": [
      "Disitamab Vedotin",
      "BCG",
      "disitamab vedotin"
    ],
    "biomarkers": [
      "HER2"
    ],
    "population": "NMIBC",
    "phase": "Phase 2",
    "trial_id": "Formula-01"
  },
  {
    "row_id": "3086P",
    "regimen": "Organ-Preserving Therapy",
    "population": "MIBC",
    "phase": "Phase 2",
    "trial_id": "Not specified",
    "drugs": [],
    "biomarkers": []
  },
  {
    "row_id": "3103P",
    "regimen": "Chemotherapy plus Toripalimab as Neoadjuvant Therapy",
    "drugs": [
      "Toripalimab",
      "toripalimab"
    ],
    "population": "UTUC",
    "line": "Neoadjuvant",
    "phase": "Phase 2",
    "trial_id": "WUTSUP-01",
    "biomarkers": []
  },
  {
    "row_id": "3081P",
    "regimen": "Bladder Preservation Therapy in Combination with Atezolizumab and Radiation therapy",
    "drugs": [
      "Atezolizumab",
      "atezolizumab"
    ],
    "population": "MIBC",
    "phase": "Not specified",
    "trial_id": "Not specified",
    "biomarkers": []
  },
  {
    "row_id": "3114eP",
    "regimen": "Disitamab Vedotin Plus Toripalimab Treatment",
    "drugs": [
      "Disitamab Vedotin",
      "Toripalimab",
      "disitamab vedotin",
      "toripalimab"
    ],
    "biomarkers": [
      "HER-2"
    ],
    "population": "MIBC",
    "line": "Neoadjuvant",
    "phase": "Not specified",
    "trial_id": "Not specified"
  },
  {
    "row_id": "3110eP",
    "regimen": "ctDNA-Guided Atezolizumab Adjuvant Therapy",
    "drugs": [
      "Atezolizumab",
      "atezolizumab"
    ],
    "population": "MIBC",
    "line": "Adjuvant",
    "phase": "Not specified",
    "trial_id": "Not specified",
    "biomarkers": []
  },
  {
    "row_id": "3104P",
    "regimen": "First-line therapy",
    "population": "mUC",
    "line": "1L",
    "phase": "Not specified",
    "trial_id": "NCDB Analysis",
    "drugs": [],
    "biomarkers": []
  },
  {
    "row_id": "967P",
    "regimen": "Nectin-4-targeting antibody-drug conjugate CRB-701",
    "drugs": [
      "CRB-701",
      "SYS6002"
    ],
    "population": "Other",
    "phase": "Phase 1/2",
    "trial_id": "SYS6002",
    "biomarkers": [
      "Nectin-4"
    ]
  },
  {
    "row_id": "LBA7",
    "regimen": "Disitamab vedotin + toripalimab versus chemotherapy",
    "drugs": [
      "Disitamab vedotin",
      "toripalimab",
      "chemotherapy",
      "disitamab vedotin"
    ],
    "population": "mUC",
    "line": "1L",
    "phase": "Not specified",
    "trial_id": "LBA7",
    "biomarkers": [
      "HER2"
    ]
  },
  {
    "row_id": "ROW_1841",
    "regimen": "optimal 1L treatment",
    "population": "mHSPC",
    "line": "1L",
    "phase": "Not specified",
    "drugs": [],
    "biomarkers": []
  },
  {
    "row_id": "ROW_1948",
    "regimen": "Optimising 1L treatment",
    "population": "mHSPC",
    "line": "1L",
    "phase": "Not specified",
    "drugs": [],
    "biomarkers": []
  },
  {
    "row_id": "ROW_2777",
    "regimen": "Optimising 1L treatment",
    "population": "mUC",
    "line": "1L",
    "phase": "Not specified",
    "drugs": [],
    "biomarkers": []
  },
  {
    "row_id": "ROW_2919",
    "population": "mUC",
    "line": "1L",
    "phase": "Not specified",
    "trial_id": "Not specified",
    "drugs": [],
    "biomarkers": []
  },
  {
    "row_id": "ROW_3207",
    "population": "MIBC",
    "phase": "Not specified",
    "trial_id": "Not specified",
    "drugs": [],
    "biomarkers": []
  },
  {
    "row_id": "1766eP",
    "biomarkers": [
      "FGFR"
    ],
    "population": "NMIBC",
    "phase": "Not specified",
    "trial_id": "Not specified",
    "drugs": []
  },
  {
    "row_id": "ROW_3477",
    "population": "mUC",
    "line": "1L",
    "phase": "Not specified",
    "trial_id": "Not specified",
    "drugs": [],
    "biomarkers": []
  },
  {
    "row_id": "1513O",
    "regimen": "GDF-15 neutralization + nivolumab",
    "drugs": [
      "GDF-15",
      "nivolumab"
    ],
    "population": "Other",
    "line": "3L",
    "phase": "Phase 2",
    "trial_id": "GDFATHER-01",
    "biomarkers": []
  },
  {
    "row_id": "52eP",
    "regimen": "PF-08052667",
    "drugs": [
      "PF-08052667"
    ],
    "modality": [
      "ADC"
    ],
    "population": "NMIBC",
    "phase": "Not specified",
    "trial_id": "Not specified",
    "biomarkers": []
  },
  {
    "row_id": "ROW_3935",
    "population": "Other",
    "phase": "Not specified",
    "trial_id": "Not specified",
    "drugs": [],
    "biomarkers": []
  },
  {
    "row_id": "ROW_4092",
    "biomarkers": [
      "emerging biomarkers"
    ],
    "population": "mUC",
    "phase": "Not specified",
    "trial_id": "Not specified",
    "drugs": []
  },
  {
    "row_id": "LBA8",
    "regimen": "circulating tumour (ct)DNA-guided adjuvant atezolizumab vs placebo",
    "drugs": [
      "atezolizumab"
    ],
    "modality": [
      "Adjuvant"
    ],
    "population": "MIBC",
    "line": "Adjuvant",
    "phase": "Phase 3",
    "trial_id": "IMvigor011",
    "biomarkers": []
  },
  {
    "row_id": "25P",
    "regimen": "KAT2A-mediated MECP2 lactylation",
    "drugs": [],
    "biomarkers": [
      "KAT2A",
      "MECP2",
      "FGF1"
    ],
    "population": "Other",
    "phase": "Not specified",
    "trial_id": "KAT2A"
  },
  {
    "row_id": "23P",
    "regimen": "HDACs inhibitor sensitizes the efficacy of cisplatin",
    "drugs": [
      "cisplatin"
    ],
    "biomarkers": [
      "H3K18la",
      "DHRS2"
    ],
    "population": "Other",
    "phase": "Not specified",
    "trial_id": "HDACs"
  },
  {
    "row_id": "CN68",
    "regimen": "Chain Mediating Effect of Family APGAR and Psychosocial Adjustment",
    "drugs": [],
    "population": "Other",
    "phase": "Not specified",
    "trial_id": "Family APGAR",
    "biomarkers": []
  },
  {
    "row_id": "LBA111",
    "regimen": "upfront Magnetic Resonance Imaging versus Transurethral Resection",
    "drugs": [],
    "biomarkers": [],
    "modality": [
      "Chemotherapy"
    ],
    "population": "mUC",
    "line": "1L",
    "phase": "Not specified",
    "trial_id": "BladderPath"
  },
  {
    "row_id": "3123eP",
    "regimen": "first-line treatment strategies",
    "drugs": [],
    "biomarkers": [],
    "modality": [],
    "population": "mUC",
    "line": "1L",
    "phase": "Not specified",
    "trial_id": ""
  },
  {
    "row_id": "3094P",
    "regimen": "enfortumab vedotin + pembrolizumab",
    "drugs": [
      "enfortumab vedotin",
      "pembrolizumab"
    ],
    "biomarkers": [],
    "modality": [
      "ADC"
    ],
    "population": "mUC",
    "line": "1L",
    "phase": "Not specified",
    "trial_id": "UNITE"
  },
  {
    "row_id": "3132eP",
    "regimen": "",
    "drugs": [],
    "biomarkers": [],
    "modality": [],
    "population": "Other",
    "line": "",
    "phase": "Not specified",
    "trial_id": ""
  },
  {
    "row_id": "3130eP",
    "regimen": "",
    "drugs": [],
    "biomarkers": [],
    "modality": [],
    "population": "mUC",
    "line": "",
    "phase": "Not specified",
    "trial_id": ""
  },
  {
    "row_id": "3101P",
    "regimen": "",
    "drugs": [],
    "biomarkers": [],
    "modality": [],
    "population": "mUC",
    "line": "",
    "phase": "Not specified",
    "trial_id": ""
  },
  {
    "row_id": "ROW_1284",
    "regimen": "",
    "drugs": [],
    "biomarkers": [],
    "modality": [],
    "population": "Other",
    "line": "",
    "phase": "Not specified",
    "trial_id": ""
  },
  {
    "row_id": "ROW_1791",
    "regimen": "",
    "drugs": [],
    "biomarkers": [],
    "modality": [],
    "population": "Other",
    "line": "",
    "phase": "Not specified",
    "trial_id": ""
  },
  {
    "row_id": "ROW_1868",
    "regimen": "",
    "drugs": [],
    "biomarkers": [],
    "modality": [],
    "population": "Other",
    "line": "",
    "phase": "Not specified",
    "trial_id": ""
  },
  {
    "row_id": "ROW_1884",
    "regimen": "",
    "drugs": [],
    "biomarkers": [],
    "modality": [],
    "population": "Other",
    "line": "",
    "phase": "Not specified",
    "trial_id": ""
  },
  {
    "row_id": "ROW_1922",
    "regimen": "",
    "drugs": [],
    "biomarkers": [],
    "modality": [],
    "population": "Other",
    "line": "",
    "phase": "Not specified",
    "trial_id": ""
  },
  {
    "row_id": "ROW_2063",
    "regimen": "",
    "drugs": [],
    "biomarkers": [],
    "modality": [],
    "population": "Other",
    "line": "",
    "phase": "Not specified",
    "trial_id": ""
  },
  {
    "row_id": "2326P",
    "regimen": "Systemic Therapy",
    "drugs": [],
    "biomarkers": [],
    "modality": [],
    "population": "MIBC",
    "line": "Not specified",
    "phase": "Not specified",
    "trial_id": "2326P"
  },
  {
    "row_id": "ROW_2203",
    "regimen": "Not specified",
    "drugs": [],
    "biomarkers": [],
    "modality": [],
    "population": "Other",
    "line": "Not specified",
    "phase": "Not specified",
    "trial_id": "ROW_2203"
  },
  {
    "row_id": "ROW_2254",
    "regimen": "Not specified",
    "drugs": [],
    "biomarkers": [],
    "modality": [],
    "population": "Other",
    "line": "Not specified",
    "phase": "Not specified",
    "trial_id": "ROW_2254"
  },
  {
    "row_id": "ROW_2255",
    "regimen": "Not specified",
    "drugs": [],
    "biomarkers": [],
    "modality": [],
    "population": "Other",
    "line": "Not specified",
    "phase": "Not specified",
    "trial_id": "ROW_2255"
  },
  {
    "row_id": "ROW_2288",
    "regimen": "Combinations with ADCs",
    "drugs": [],
    "biomarkers": [],
    "modality": [
      "ADC"
    ],
    "population": "Other",
    "line": "Not specified",
    "phase": "Not specified",
    "trial_id": "ROW_2288"
  },
  {
    "row_id": "ROW_2700",
    "regimen": "Not specified",
    "drugs": [],
    "biomarkers": [],
    "modality": [],
    "population": "Other",
    "line": "Not specified",
    "phase": "Not specified",
    "trial_id": "ROW_2700"
  },
  {
    "row_id": "ROW_2702",
    "regimen": "Not specified",
    "drugs": [],
    "biomarkers": [],
    "modality": [],
    "population": "Other",
    "line": "Not specified",
    "phase": "Not specified",
    "trial_id": "ROW_2702"
  },
  {
    "row_id": "ROW_2705",
    "regimen": "Not specified",
    "drugs": [],
    "biomarkers": [],
    "modality": [],
    "population": "Other",
    "line": "Not specified",
    "phase": "Not specified",
    "trial_id": "ROW_2705"
  },
  {
    "row_id": "ROW_2874",
    "regimen": "Not specified",
    "drugs": [],
    "biomarkers": [],
    "modality": [],
    "population": "Other",
    "line": "Not specified",
    "phase": "Not specified",
    "trial_id": "ROW_2874"
  },
  {
    "row_id": "ROW_3093",
    "regimen": "Not specified",
    "drugs": [],
    "biomarkers": [],
    "modality": [],
    "population": "Other",
    "line": "Not specified",
    "phase": "Not specified",
    "trial_id": "ROW_3093"
  },
  {
    "row_id": "24P",
    "regimen": "Cancer cell reprogramming",
    "drugs": [],
    "biomarkers": [],
    "modality": [],
    "population": "Other",
    "line": "Not specified",
    "phase": "Not specified",
    "trial_id": "24P"
  },
  {
    "row_id": "ROW_3302",
    "regimen": "Microbiome",
    "drugs": [],
    "biomarkers": [],
    "modality": [],
    "population": "Other",
    "line": "Not specified",
    "phase": "Not specified",
    "trial_id": "ROW_3302"
  },
  {
    "row_id": "ROW_3401",
    "regimen": "Shared decision-making in la/mUC",
    "drugs": [],
    "biomarkers": [],
    "modality": [],
    "population": "mUC",
    "line": "Not specified",
    "phase": "Not specified",
    "trial_id": "ROW_3401"
  },
  {
    "row_id": "ROW_3455",
    "regimen": "Novel imaging",
    "drugs": [],
    "biomarkers": [],
    "modality": [],
    "population": "Other",
    "line": "Not specified",
    "phase": "Not specified",
    "trial_id": "ROW_3455"
  },
  {
    "row_id": "3052eP",
    "regimen": "KDM6A deficiency assessment",
    "drugs": [],
    "biomarkers": [
      "KDM6A"
    ],
    "modality": [],
    "population": "mUC",
    "line": "Not specified",
    "phase": "Not specified",
    "trial_id": "3052eP"
  },
  {
    "row_id": "245eP",
    "regimen": "Urine biomarkers assessment",
    "drugs": [],
    "biomarkers": [],
    "modality": [],
    "population": "Other",
    "line": "Not specified",
    "phase": "Not specified",
    "trial_id": "245eP"
  },
  {
    "row_id": "62eP",
    "regimen": "Metabolic regulation of metastasis",
    "drugs": [],
    "biomarkers": [
      "ARHGDIB"
    ],
    "modality": [],
    "population": "Other",
    "line": "Not specified",
    "phase": "Not specified",
    "trial_id": "62eP"
  },
  {
    "row_id": "ROW_3677",
    "regimen": "Clinical insights in MIBC",
    "drugs": [],
    "biomarkers": [],
    "modality": [],
    "population": "MIBC",
    "line": "Not specified",
    "phase": "Not specified",
    "trial_id": "ROW_3677"
  },
  {
    "row_id": "ROW_3749",
    "regimen": "Real-world evidence in la/mUC",
    "drugs": [],
    "biomarkers": [],
    "modality": [],
    "population": "mUC",
    "line": "Not specified",
    "phase": "Not specified",
    "trial_id": "ROW_3749"
  },
  {
    "row_id": "ROW_4187",
    "regimen": "Soluble biomarkers",
    "drugs": [],
    "biomarkers": [],
    "modality": [],
    "population": "Other",
    "line": "Not specified",
    "phase": "Not specified",
    "trial_id": "ROW_4187"
  },
  {
    "row_id": "ROW_4245",
    "regimen": "Epigenetics and spatial genomics",
    "trial_id": "ROW_4245",
    "drugs": [],
    "biomarkers": []
  }
]